Clinical Trial Update: A Study of RPL554 in Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 study of RPL554 in cystic fibrosis completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• RPL554 (RPL554)

Snippet

Sponsor: Verona Pharma plc | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-20